Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Camp4 Therapeutics Corporation has 1 pending office action in Biotechnology & Pharmaceuticals. The profile identifies 1 distinct examiner and 1 distinct art unit. BAILEY, STEVEN WILLIAM is the busiest examiner, with 1 pending matter. The recorded prosecution activity is concentrated in one examination path for the company’s therapeutic subject matter.
Counsel should focus on the examiner’s grounds and on a claim presentation that clearly connects the therapeutic features to the application disclosure. Any response should distinguish the cited art without surrendering unnecessary scope. Because the profile contains one examiner and one art-unit assignment, the prosecution team can maintain a coherent argument and amendment strategy throughout the pending matter.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAILEY, STEVEN WILLIAM | 1 | 31.6% | +15.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18177284 | CHARACTERIZING FUNCTIONAL REGULATORY ELEMENTS USING MACHINE LEARNING | BAILEY, STEVEN WILLIAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18177284 | CHARACTERIZING FUNCTIONAL REGULATORY ELEMENTS USING MACHINE LEARNING | BAILEY, STEVEN WILLIAM | — |
| Art Unit | Apps |
|---|---|
| 1687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18177284 | CHARACTERIZING FUNCTIONAL REGULATORY ELEMENTS USING MACHINE LEARNING | BAILEY, STEVEN WILLIAM | 1687 | §101§103§112 | Non-Final OA | — | Pending | Mar 02, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCamp4 Therapeutics Corporation has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Steven William Bailey has the most, with 1 of Camp4 Therapeutics Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
